Widler & Schiemann
Your Partner in Custom Quality Management Solutions
Strategic Drug Development
Widler & Schiemann is a global team of customer-focused thought leaders in quality management and strategic drug development solutions
Founded in 2012, the specialists at Widler & Schiemann have on average 20+ years of experience in the pharmaceutical and biotech industries. With this broad range of expertise and knowledge of drug development, we support our clients throughout the lifecycle of their projects, from manufacturing and pre-clinical studies to post approval commitment trials.
Our extensive track record and advisory role with regulators (FDA, EMA, NMPA, BfArM, Swissmedic, et al) and organizations (e.g. WHO, OECD, CTTI & ACRES) positions us uniquely to ensure our clients benefit from the latest developments in methodologies, while maintaining compliance with the most recent changes in laws and regulations.
With our extensive network of associate partners and contractors, we can offer audits in every discipline across every geographical location.